المؤلفون: Duvic M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. mduvic@mdanderson.org, Geskin L, Prince HM

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2013 Aug; Vol. 13 (4), pp. 377-84. Date of Electronic Publication: 2013 Jun 14.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Diphtheria Toxin/*therapeutic use , Interleukin-2/*therapeutic use , Lymphoma, T-Cell, Cutaneous/*drug therapy , Skin Neoplasms/*drug therapy, Antineoplastic Agents/adverse effects ; Diphtheria Toxin/adverse effects ; Female ; Humans ; Interleukin-2/adverse effects ; Lymphoma, T-Cell, Cutaneous/pathology ; Male ; Middle Aged ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/therapeutic use ; Skin Neoplasms/pathology ; Treatment Outcome